相关实验视频

Updated: May 1, 2026

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 13, 2014

[可切除PCNBs的术前免疫疗法治疗]

Mariona Riudavets¹, Gary Birsen¹, Jeremy Slomka¹

¹Service de Pneumologie et Oncologie thoracique, Hôpital Cochin, Assistance publique-Hôpitaux de Paris, Institut du Cancer Paris CARPEM, Paris, France.

Bulletin du cancer

|March 28, 2025

概括

外科手术期间的免疫检查点抑制剂通过降低高复发率,为早期非小细胞肺癌 (NSCLC) 提供了新的希望. 这种方法正在改变局部NSCLC治疗模式.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
胸部外科手术胸部外科手术

背景情况:

早期非小细胞肺癌 (NSCLC) 历史上面临着高复发率,尽管有可能切除.
抗PD(L) 1免疫检查点抑制剂在晚期NSCLC中表现出成功.
最近的批准允许局部NSCLC的外科手术期间使用.

研究的目的:

审查外科手术期间免疫检查点抑制剂在可切除NSCLC中的作用.
综合早期临床试验的发现.
讨论未来的治疗方向.

主要方法:

早期临床试验的文献综述.
在可切除的NSCLC中对外科手术期间的抗PD(L) 1治疗的综合数据.
讨论新兴的治疗模式.

主要成果:

周周手术免疫检查点抑制剂在治疗局部NSCLC方面表现出潜在的潜力.
早期的试验表明,它对当前的治疗策略产生了变革性的影响.
这种方法解决了可切除NSCLC的高复发率.

结论:

周周手术免疫检查点抑制剂代表了局部NSCLC的范式转变.
进一步的研究和临床试验对于优化这种治疗策略至关重要.
这种方法有望改善可切除NSCLC的结果.

关键词:

在CPNPCPC中使用.免疫疗法是新辅助疗法.在NSCLCLC中,我们可以看到.新辅助免疫疗法新辅助免疫疗法在外科手术期间.这是一个经营区 (peri-opératoire).

更多相关视频

A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation

A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation

Published on: June 8, 2018

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.